Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
PTG-300-11
Clinical Trial Grant
Duke Scholars
Principal Investigator
Lindsay Anne Magura Rein
Medicine, Hematologic Malignancies and Cellular Therapy
Administered By
Duke Cancer Institute
Awarded By
Protagonist Therapeutics Inc.
Start Date
July 26, 2022
End Date
July 31, 2027
Administered By
Duke Cancer Institute
Awarded By
Protagonist Therapeutics Inc.
Start Date
July 26, 2022
End Date
July 31, 2027
